论文部分内容阅读
本文就日本22个医院进行的同种骨髓移植(ABMT)首次完全缓解的123例急性白血病患者作了回顾性分析,其中接受全身照射(TBI)组为81例,未接受全身照射(NTBI)用白消安(Bu)、环磷酰胺(Cy)和其它药物组为42例。TBI组和NTBI组的急性淋巴细胞白血病(ALL)和急性非淋巴细胞白血病(ANLL)分别为36和17例,45和25例,TBI组中位年龄22岁(1～44岁),男44例,女37例。NTBI组中位年龄22.5岁(1～44岁),男29例,女13例。TBI35例接受TBI/Cy,25例接受TBI/Cy和其它药物,13例接受Ara-c,9例接
In this paper, we retrospectively analyzed 123 acute leukemia patients with complete remission of allogeneic bone marrow transplantation (ABMT) performed in 22 hospitals in Japan. Among them, 81 received TBI and 81 received NTBI There were 42 cases of busulfan, cyclophosphamide and other drugs. The rates of acute lymphoblastic leukemia (ALL) and acute non-lymphocytic leukemia (ANLL) in TBI and NTBI groups were 36 and 17, 45 and 25, respectively. The median age of TBI patients was 22 years (range, 1 to 44 years) Cases, female 37 cases. The median age of 22.5 years (range, 1 to 44 years) in NTBI group was 29 males and 13 females. Thirteen patients received TBI / Cy, 25 received TBI / Cy and other drugs, 13 received Ara-c, and 9 received